Starton Therapeutics scraps SPAC deal that would have taken it public, brought in $50M
Starton Therapeutics, which had planned to go public this year in a SPAC merger, said Friday that the $50 million deal …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
